Journal Article (Letter)

DKFZ-2023-02124

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas.

Zhao, B. (First author)DKFZ* ; Qi, H.DKFZ* ; Ma, W.

2023
American Medical Association Chicago, Ill.

This record in other databases:  

Please use a persistent id in citations: doi:10.1001/jamaoncol.2023.4736

Note: #EA:D170# / 2023 Dec 1;9(12):1734-1735

---

Contributing Institute(s):

1. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
2. DKTK HD zentral (HD01)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2023

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF >= 25 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---